Comparative activity of carbapenem testing: the COMPACT study
Patrice Nordmann(University of Fribourg), Vittorio Sambri(Azienda Unità Sanitaria Locale Della Romagna), Robert K. Flamm(JMI Laboratories), Marianne Abele‐Horn(Quotient Clinical (United Kingdom)), Khalid El-Bouri(Janssen (Switzerland)), Gian María Rossolini(University of Siena), Guido Fadda(University of Messina), Giacomo Fortina(Janssen (Switzerland)), M. Morgan(Johnson & Johnson (United States)), Giovanni Gesu, Helena Žemličková, Cécile Bébéar(Centre National de la Recherche Scientifique), E. Jacobs(Janssen (Switzerland)), M. R. Delvallez(Quotient Clinical (United Kingdom)), W. Pfister, J. Hanzen(Inserm), Reinier Mutters, O. Paniara, J. Papaparaskevas(Johnson & Johnson (Germany)), D Kotulová(Quotient Clinical (United Kingdom)), Harald Seifert(German Center for Infection Research), Pierre‐Yves Levy(Inserm), J. C. H. Seak(Johnson & Johnson (Germany)), Alvaro Quintana(Johnson & Johnson (United States)), Francesca Milano(Janssen (Switzerland)), Leopoldo Paolo Pucillo(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Ian Morrissey, Joerg Laeuffer(Janssen (Switzerland)), David Waghorn, Édouard Bingen(Délégation Paris 7), G. Nicoletti(Johnson & Johnson (United States)), Esther Manso(Johnson & Johnson (United States)), F. Jehl, B S Azadian(Johnson & Johnson (Germany)), C. Schoerner(Johnson & Johnson (Germany)), M. Campa(Janssen (Switzerland)), U. Mai, R. Rigoli(Janssen (Switzerland)), B. Oppenheim(Inserm), E.G. Smyth(Quotient Clinical (United Kingdom)), R. Bonnet(Johnson & Johnson (United States)), Juan J. Picazo, B. Masterton(Quotient Clinical (United Kingdom)), Greg Jones(Johnson & Johnson (United States)), H. Piotr(Quotient Clinical (United Kingdom)), Volkan Korten(University of California San Diego)
Cited by 50
Related Papers
CTX-M: changing the face of ESBLs in Europe
|Journal of Antimicrobial Chemotherapy|2006|923
Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread
|Nature Microbiology|2019|817
Dissemination of Clonally Related<i>Escherichia coli</i>Strains Expressing Extended-Spectrum β-Lactamase CTX-M-15
|Emerging infectious diseases|2008|699
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium
|Clinical Microbiology and Infection|2007|575
Worldwide Dissemination of the NDM-Type Carbapenemases in Gram-Negative Bacteria
|BioMed Research International|2014|485